Robert I Blum sold $471K of CYTK stock

Robert I Blum, President & CEO of Cytokinetics Inc (CYTK), sold 7,500 shares of CYTK stock worth $471K, per an SEC Form 4 filed Nov 2, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade was reported on Nov 2, 2026.

CYTK has moved -5.6% since the trade date, from $62.03 to $58.53 (Nov 11, 2026 close).